Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077285
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-02
First Post:
2004-02-10
Brief Title:
Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
2024-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10
Completion Date Type:
ESTIMATED
First Submit Date:
2004-02-10
First Submit QC Date:
February 10 2004
Study First Post Date:
2004-02-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-01
Last Update Post Date:
2023-11-02
Last Update Post Date Type:
ACTUAL